TransMedics to equip all 22 Phenom 300Es with Gogo Galileo HDX by 2027

TransMedics has selected Gogo Galileo HDX inflight connectivity for its fleet of 22 Embraer Phenom 300E aircraft, with installations already under way and full fleet coverage targeted by mid-2027. The agreement makes continuous, real-time monitoring of donor organs possible on every flight the operator conducts across the United States.

TransMedics is an organ transplantation technology, services and logistics company. Its aircraft perform time-critical transport missions in which the condition of each organ must be tracked throughout the flight. According to Gogo, organs on each mission are continuously monitored in transit using TransMedics' Organ Care System (OCS), a portable device that keeps donor organs viable outside the body. That dependency makes reliable, high-bandwidth connectivity central to the operation rather than an amenity.

What does the fleet-wide fit change for organ logistics?

The retrofit moves connectivity from an occasional capability to a fleet standard. Andre Costa, VP of Global Logistics at TransMedics, framed the milestone in direct operational terms: "Every flight we operate carries the potential to save a life, which makes continuous, real-time visibility into each organ's status during transport mission-critical."

Costa said the company selected Gogo Galileo on three technical criteria beyond raw bandwidth. "We selected Gogo Galileo not only for the reliable, high-performance connectivity these critical missions demand, but also for the cybersecurity, system redundancy, and active monitoring that Gogo delivers to its customers," he said.

The timeline is specific. Installations are already in progress across the fleet, and Costa confirmed the mid-2027 completion date. "By mid-2027, Gogo Galileo will be operating across our entire fleet, making TransMedics the first and only organ transplant company to achieve this milestone, and we plan to extend this capability to our European fleet in 2028," he said.

That 2028 extension signals the program's trajectory: a second region, a second set of aircraft, and a repeat of the certification and installation cycle on a new regulatory territory.

The network behind the connection

Gogo Galileo runs on Eutelsat OneWeb's enterprise-grade low Earth orbit (LEO) constellation, which uses satellites orbiting at several hundred kilometers' altitude to deliver low-latency broadband to aircraft in flight. For missions where organ status data must flow without interruption, the LEO architecture offers global coverage that legacy air-to-ground systems cannot match over water or remote regions.

Chris Moore, CEO of Gogo, positioned the contract as evidence of business aviation's reach beyond corporate travel. "Business aviation supports far more than executive travel: it enables critical missions that communities rely on every day," Moore said. "TransMedics is a powerful example of that. When you're transporting donor organs, connectivity isn't a convenience; it's part of the mission."

A measured deployment schedule

The program separates cleanly into what is flying today and what is promised. Installations are under way now, with aircraft already operating Galileo HDX. The fleet-wide deadline sits in mid-2027, and the European expansion follows in 2028.

For the connectivity market, the contract gives Gogo a high-visibility reference customer in the medical logistics segment, one where downtime carries consequences beyond cost. For TransMedics, the retrofit standardizes a capability the company describes as mission-critical across every aircraft it flies. The next checkpoint to watch is whether the European fleet integration in 2028 stays on the schedule Costa laid out.